|BioElectronics Receives Nationwide CBS News Coverage|
|Monday, 10 August 2009 05:04|
"The number of press and analyst inquiries we are receiving is impressive," commented Andrew Whelan, CEO at BioElectronics, Corp. "Members of the press and many financial analysts have shown a keen interest in the Tylenol and acetaminophen safety debate and are paying particular attention to drug-free therapies, such as those offered by BioElectronics. Over the next few months our stakeholders should expect to see coverage of the Company continue to accelerate as the FDA takes formal action relative to these issues. We believe we have a revolutionary set of products that will allow us to rewrite pain management and healing over the next few years. It is truly an exciting time for all of us at BioElectronics as we continue our clinical trials and as we prepare additional FDA filings seeking over the counter clearance for our products."
The latest news story can be viewed on the CBS News website at the following link --
Over the past few weeks there have been numerous other news stories and analyst reports on the Company. We have listed a few of these links below:
About BioElectronics Corporation
BioElectronics Corporation is the maker of ActiPatch® Therapy, RecoveryRx™ Devices, HealFast™ Therapy (www.healfasttherapy.com) and the Allay™ family of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see http://www.BioElectronicsCorp.com.
Tylenol is a registered trademark of McNeil pharmaceutical, Inc.